4】报告题目 现代智能科技与中华药食同源健康产业欧洲市场运营分析报告

                     第二届食药物质健康中国国际高峰论坛

                  暨"菩惠宁"癌瘤非药物干预产品功效认证新闻发布会

                       生物智能健康协会（波兰）

                     Jimmy 科技供应链公司（波兰）

                   中东欧—中国进出口商协会（波兰）副会长 刘平

摘要：中国药食同源产业依托“药食同根、食疗同源”的千年智慧，叠加现代智能科技的全链条赋能，正成为全球健康消费的新增长极，欧洲作为全球功能性食品与天然健康产品的核心市场，消费者对天然、有机、精准营养的需求旺盛，为药食同源产品提供了广阔空间。

关键词：产业融合 智能科技赋能药食同源全链条

论述：1. AI 驱动研发与配方优化

AI 整合多组学（基因组、代谢组、微生物组）数据，解析枸杞、黄芪、茯苓等原料的活性成分（如多糖、皂苷）与作用靶点，快速筛选适配欧洲慢病（失眠、代谢综合征、免疫力低下）的配方，研发周期缩短 30%-52%。

2. 智能制造与精准质控：自动化生产线实现原料清洗、萃取、制粒、包装全流程可控；近红外光谱、AI

视觉质检替代人工抽检，100%在线品控，解决传统产品批次差异问题；低温破壁、超临界萃取技术提升有

效成分吸收率至 90%以上，适配欧洲对高效成分的需求。

3.区块链全链路溯源：从道地药材种植、加工、仓储到终端销售，区块链记录全流程数据，生成唯一溯源

码，满足欧盟《通用食品法规》（Regulation (EC) No 178/2002）的溯源要求，破解信任壁垒。

4. 智能硬件+个性化服务：可穿戴设备（智能戒指、手环）监测睡眠、血糖、压力等数据，AI 算法实时推

荐定制化方案，打造“硬件+产品+服务”模式，提升用户粘性。

总结：欧洲市场环境分析

(一) 市场规模与增长潜力

欧洲是全球第二大功能性食品市场，2024 年市场规模超 800 亿欧元，年复合增长率约 5.8%，其中天然草本补充剂、植物基健康食品增速超 10%。药食同源相关产品（草本茶、植物提取物、功能性代餐）应用率持续提升。

(二) 政策法规壁垒

1. 产品分类监管：欧盟将药食同源产品分为三类——食品补充剂（准入门槛低，需符合 EC

1924/2006）、传统草药制剂（需符合 EMA 传统草药注册指令，需 7 年以上使用历史）、新药（需

完整临床试验，门槛最高）。目前仅 7 种中药类草药制剂获 EMA 批准，多数产品以食品补充剂

身份进入市场。

2. 成分与标签限制：禁止使用濒危药材（如野生人参、石斛）；标签需标注成分含量、营养声称、

过敏原信息，重金属、农药残留需符合欧盟 EC 1881/2006 标准。

3. 知识产权保护：欧盟对配方专利、地理标志（GI）保护严格，企业需提前布局专利，避免侵权

风险。

4】Report topic:European Market Operation Analysis Report of Modern Intelligent Technology and Chinese Medicine

and Food Same Origin Health Industry

The 2nd China International Summit Forum on Food and Drug Quality Health

Press conference on efficacy certification of  cancer tumour non-drug intervention products

Bio-Intelligent Health Association (Poland)

Jimmy Technology Supply Chain Company (Poland)

Central and Eastern Europe - China Importers and Exporters Association (Poland) Vice President Ping Liu

Abstract：Relying on the thousand-year wisdom of "the same root of medicinal food and the same origin of food and

the same origin of food", superimposed on the whole chain of modern intelligent technology, China's pharmaceutical food industry is becoming a new growth pole for global health consumption. As the core market for global functional food and natural health products, Europe has a strong demand for natural, organic and precise nutrition, providing a broad space for medicinal food products of the same origin.

Keyword：Industrial integration Intelligent technology empowers the whole chain of the same source of medicine

and food Expound：1.AI-driven research and development and formula AI integrates and targets of  and other raw materials, and quickly screens

formulas suitable for European chronic diseases (insomnia, metabolic syndrome, low immunity), and shortens the research and development cycle by 30%-52%.

2.Intelligent manufacturing and precise quality control: the automated production line realises the control of the whole process of raw material cleaning, extraction, granulation and packaging; near-infrared spectrum and AI visual quality inspection replace manual sampling, 100% online quality control, and solve

3. the problem of batch difference of traditional products; low-temperature wall-breaking and supercritical extraction technology improve the absorption rate of active ingredients to more than 90%, adapting to Europe's demand for high-efficiency ingredients.

full-link traceability: From the planting, processing, warehousing to terminal sales of local medicinal

materials,  records the whole process data and generates a unique traceability code to meet the traceability requirements of the General Food Regulation (EC) No 178/2002 and break down the trust barrier.

4.Intelligent hardware +service: wearable devices (smart rings, bracelets) monitor sleep, blood sugar,

stress and other data, and AI algorithms recommend solutions in real time to create a "hardware + product+ service" model and improve user stickiness.

Conclusion： European market environment analysis

（一）Market size and growth potential

Europe is the world's second largest functional food market, with a market size of more than 80 billion euros in 2024,with a compound annual growth rate of about 5.8%, of which the growth rate of natural herbal supplements andplant-based health foods exceeds 10%. The penetration rate of medicinal food-related products (herbal tea, plant

extracts, functional meal replacement) continues to improve.

（二）Barriers of policies and regulations

1.Product classification supervision: The European Union divides medicinal and food products of the same origin into three categories - food supplements (low access threshold, need to comply with EC 1924/2006), traditional herbal

preparations (need to comply with the EMA traditional herbal registration instructions, need more than 7 years of use history), new drugs (requires complete clinical trials, the threshold is the highest) At present, only 7 traditional Chinese herbal preparations have been approved by EMA, and most of the products have entered the market as food supplements.

2.Ingredient and la restrictions: The use of endangered medicinal materials (such as wild ginseng and is prohibited; the label should indicate the ingredient content, nutritional claim and information,and heavy metals and pesticide residues should meet the EU EC 1881/2006 standard.

3.Intellectual property protection: The European Union strictly protects formula patents and geographical indications (GI), and enterprises need to arrange patents in advance to avoid the risk of infringement.

编辑：食药物质国际交流栏目组  愚晏

翻译：国际食药物质与健康产业联盟 执行秘书长 孙丽

校对：国际疾病非药物干预科学应用联盟（中国代表处）执行秘书长 吴玲